GEP19970992B - Implant for Parenteral Introducing with Controlled Speed - Google Patents

Implant for Parenteral Introducing with Controlled Speed

Info

Publication number
GEP19970992B
GEP19970992B GEAP19931351A GEAP1993001351A GEP19970992B GE P19970992 B GEP19970992 B GE P19970992B GE AP19931351 A GEAP19931351 A GE AP19931351A GE AP1993001351 A GEAP1993001351 A GE AP1993001351A GE P19970992 B GEP19970992 B GE P19970992B
Authority
GE
Georgia
Prior art keywords
implant
core
peptide
biologically active
polypeptide
Prior art date
Application number
GEAP19931351A
Other languages
English (en)
Inventor
Theresa Rise
David Farley Johnson
Susan Mancini Cady
William David Steber
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GEP19970992B publication Critical patent/GEP19970992B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/10—Stiffening bandages containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
GEAP19931351A 1991-06-24 1993-07-31 Implant for Parenteral Introducing with Controlled Speed GEP19970992B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71989891A 1991-06-24 1991-06-24

Publications (1)

Publication Number Publication Date
GEP19970992B true GEP19970992B (en) 1997-11-20

Family

ID=24891827

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19931351A GEP19970992B (en) 1991-06-24 1993-07-31 Implant for Parenteral Introducing with Controlled Speed

Country Status (24)

Country Link
EP (1) EP0523330B1 (enEXAMPLES)
JP (1) JP3597205B2 (enEXAMPLES)
KR (1) KR100221031B1 (enEXAMPLES)
CN (1) CN1050301C (enEXAMPLES)
AT (1) ATE135565T1 (enEXAMPLES)
AU (1) AU656200B2 (enEXAMPLES)
BR (1) BR9202374A (enEXAMPLES)
CA (1) CA2071757C (enEXAMPLES)
DE (1) DE69209173T2 (enEXAMPLES)
DK (1) DK0523330T3 (enEXAMPLES)
ES (1) ES2087337T3 (enEXAMPLES)
GE (1) GEP19970992B (enEXAMPLES)
GR (1) GR3019457T3 (enEXAMPLES)
HU (1) HU217547B (enEXAMPLES)
IE (1) IE74398B1 (enEXAMPLES)
IL (1) IL102287A (enEXAMPLES)
LV (1) LV11816B (enEXAMPLES)
MD (1) MD1394G2 (enEXAMPLES)
MX (1) MX9203175A (enEXAMPLES)
RU (1) RU2080119C1 (enEXAMPLES)
SG (1) SG47955A1 (enEXAMPLES)
TW (1) TW215058B (enEXAMPLES)
UA (1) UA26137C2 (enEXAMPLES)
ZA (1) ZA924613B (enEXAMPLES)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
ES2389627T3 (es) * 1998-07-20 2012-10-29 Virbac (Australia) Pty Ltd Formulación para bioimplantes
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
KR100890679B1 (ko) 2000-02-24 2009-03-26 일라이 릴리 앤드 캄파니 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
US6719992B2 (en) 2000-06-26 2004-04-13 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
JP2005145821A (ja) * 2003-11-11 2005-06-09 Kao Corp 打錠製剤
JP2013515080A (ja) 2009-12-21 2013-05-02 アンブルックス，インコーポレイテッド 修飾されているウシのソマトトロピンポリペプチドおよびそれらの使用
PE20121799A1 (es) 2009-12-21 2013-01-02 Ambrx Inc Polipeptidos de somatotropina porcina modificados y sus usos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
HUT69680A (en) * 1990-08-09 1995-09-28 Endocon Inc Implant and apparatus for delivering multiple drug and process for production of theese

Also Published As

Publication number Publication date
KR100221031B1 (ko) 1999-09-15
CA2071757A1 (en) 1992-12-25
CN1050301C (zh) 2000-03-15
JPH05186363A (ja) 1993-07-27
ZA924613B (en) 1993-03-31
ATE135565T1 (de) 1996-04-15
RU2080119C1 (ru) 1997-05-27
EP0523330A1 (en) 1993-01-20
HUT61486A (en) 1993-01-28
MD1394F2 (en) 2000-01-31
AU656200B2 (en) 1995-01-27
SG47955A1 (en) 1998-04-17
IE922020A1 (en) 1992-12-30
IE74398B1 (en) 1997-07-30
IL102287A0 (en) 1993-01-14
ES2087337T3 (es) 1996-07-16
EP0523330B1 (en) 1996-03-20
LV11816B (en) 1997-12-20
CA2071757C (en) 2003-06-10
AU1847092A (en) 1993-01-07
TW215058B (enEXAMPLES) 1993-10-21
IL102287A (en) 2000-06-01
DK0523330T3 (da) 1996-04-15
KR930000131A (ko) 1993-01-15
CN1068965A (zh) 1993-02-17
BR9202374A (pt) 1993-01-26
MD1394G2 (ro) 2000-11-30
MX9203175A (es) 1993-04-01
MD940370A (en) 1996-06-28
JP3597205B2 (ja) 2004-12-02
DE69209173D1 (de) 1996-04-25
HU217547B (hu) 2000-02-28
UA26137C2 (uk) 1999-06-07
DE69209173T2 (de) 1996-11-28
HU9202092D0 (en) 1992-09-28
GR3019457T3 (en) 1996-06-30
LV11816A (lv) 1997-08-20

Similar Documents

Publication Publication Date Title
GEP19970992B (en) Implant for Parenteral Introducing with Controlled Speed
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
RU2002130192A (ru) Способ лечения или предупреждения ожирения
FI962559A0 (fi) Hormonaaliseen raskauden ehkäisyyn ja/tai aknen hoitoon tarkoitettu lääke ja menetelmä
ATE273996T1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
LTIP702A (en) A slimming pharmaceutical composition
GR3030382T3 (en) Cytokine restraining agents.
EP1023905A3 (en) Pharmaceutical composition containing S-nitroso-immunoglobulins and use thereof
EP0592569A4 (en) COMPOSITION AND METHOD FOR TRANSDERMAL ADMINISTRATION OF DICLOFENAC.
RU2000100346A (ru) Способы лечения ожирения
CA2189250A1 (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
WO1994027589A3 (en) Antidepressant dosage form
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
GEP19991515B (en) Pharmaceutical Composition
GR3031459T3 (en) Wound treatment employing biologically active peptides
EP0556285A4 (en) Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
AU5743194A (en) Treatment of dermatological malignancies with biologically active peptides
UA27048C2 (uk) Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
AU3909389A (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
ES2024729A6 (es) Metodo de ensayar muestras desconocidas de fluido biologico para detectar peptidos formadores de canales de iones.
EP0269017A3 (en) Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein
EP0335597A3 (en) Use of a polypeptide in the preparation of a composition for the treatment of pancreatitis
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds